STOCK TITAN

Dermata Therapeutics, Inc. Warrant (DRMAW) Total Assets by Year

DRMAW

Dermata Therapeutics, Inc. Warrant closed fiscal year 2025 with $7.9M in total assets, $1.6M in total liabilities and $6.2M in shareholder equity. This represents an increase of 122.5% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Dermata Therapeutics, Inc. Warrant has filed alongside them.

FY2025 annual
Total Assets $7.9M
Total Liabilities $1.6M
Total Equity $6.2M
YoY +122.5%
5Y CAGR +67.0%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

DRMAW Balance Sheet by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-K
Total Assets$7.9M+122.5%$3.5M-55.7%$8.0M+14.9%$6.9M-40.3%$11.6M+1819.9%$605K
Total Liabilities$1.6M-16.8%$2.0M+21.5%$1.6M+76.0%$923K-39.2%$1.5M-59.9%$3.8M
Total Equity$6.2M+298.7%$1.6M-75.4%$6.4M+5.5%$6.0M-40.4%$10.1M+418.0%-$3.2M

DRMAW Balance Sheet by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Total Assets$5.3M-19.9%$7.5M-25.4%$7.9M+122.5%$5.1M-24.2%$6.6M+26.8%$10.0M+93.2%$3.5M-55.7%$6.7M-8.7%$5.2M-39.9%$5.2M-44.3%$8.0M+14.9%$7.3M-18.4%
Total Liabilities$1.8M+78.6%$1.1M-61.1%$1.6M-16.8%$1.1M-42.9%$1.0M-46.5%$2.7M+97.1%$2.0M+21.5%$1.9M+112.3%$1.9M+180.9%$1.4M+13.6%$1.6M+76.0%$917K-39.1%
Total Equity$3.5M-37.9%$6.4M-12.2%$6.2M+298.7%$4.0M-16.5%$5.6M+69.2%$7.3M+91.7%$1.6M-75.4%$4.7M-26.0%$3.3M-58.7%$3.8M-52.9%$6.4M+5.5%$6.4M-14.2%

What total assets means

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.

More Dermata Therapeutics, Inc. Warrant financials

Frequently Asked Questions

What was Dermata Therapeutics, Inc. Warrant's total assets in fiscal year 2025?

Dermata Therapeutics, Inc. Warrant closed fiscal year 2025 with $7.9M in total assets, $1.6M in total liabilities and $6.2M in shareholder equity.

How fast is Dermata Therapeutics, Inc. Warrant's total assets growing?

Dermata Therapeutics, Inc. Warrant (DRMAW) total assets rose by 122.5% year over year, from $3.5M to $7.9M in fiscal year 2025.

How has Dermata Therapeutics, Inc. Warrant's total assets changed over the years?

Across the 6 fiscal years this page covers, Dermata Therapeutics, Inc. Warrant (DRMAW) total assets went from $605K in fiscal year 2020 to $7.9M in fiscal year 2025.

Dermata Therapeutics, Inc. Warrant (DRMAW) reported $5.3M in total assets in Q2 2026. This represents a decrease of 19.9% from the same quarter a year earlier.

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Dermata Therapeutics, Inc. Warrant (DRMAW) reported on that line in every period on record.